Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder

Open-Label Uridine for Treatment of Depressed Adolescents with Bipolar Disorder

This report is an open-label case series of seven depressed adolescents with bipolar disorder treated with uridine for 6 weeks. Treatment response was measured with the Children's Depression Rating Scale-Revised and the Clinical Global Impressions scale. Uridine was associated with decreased depressive symptoms, and was well tolerated by study participants. Further systematic studies of uridine are warranted.

Scientific Studies & Papers

Author of Study or Paper
Kondo DG1, Sung YH, Hellem TL, Delmastro KK, Jeong EK, Kim N, Shi X, Renshaw PF.
Source
The Brain Institute, University of Utah, Salt Lake City, Utah
Date Published
2011

Content Copyright 2011 - 2024  LimitlessMindset.com. All Rights Reserved.

  • All trademarks, logos, and service marks displayed are registered and/or unregistered Trademarks of their respective owners.
  • Reproduction in whole or in any form without express written permission is prohibited.
  • This is not medical advice.
  • The content on this website is for entertainment purposes.
  • These statements have not been evaluated by the Food and Drug Administration.
  • These products are not intended to treat, cure, prevent, or diagnose any disease.

Website by Roseland Digital